Join us for rapid abstract presentations on cutting-edge kidney cancer research. Topics include:
“Enrichment of Tertiary Lymphoid Structures Provides Novel Insight into Mediators of Anti-Tumor Immune Activity in Sarcomatoid Renal Cell Carcinoma” by Nicholas Salgia, Roswell Park Comprehensive Cancer Center
“Tumor Evolution of Brain-Specific Tropism in Metastatic Renal Cell Carcinoma” by Roy Elias, Johns Hopkins
“Impact of Latino Ethnicity on the Gut Microbiome Composition of Patients with Metastatic Renal Cell Cancer (mRCC)” by Regina Barragan-Carrillo, City of Hope Comprehensive Cancer Center
“Natural Killer Cells Have Impaired Cytotoxicity in Advanced Renal Cell Carcinoma” by Vivien Moritz, Yale School of Medicine
“Development of an Ex Vivo Patient-Derived Tumor Model (PDTM) to Assess the Tumor Microenvironment in Renal Cell Carcinoma (RCC)” by Soki Kashima, Yale School of Medicine
“Fasting Mediated Gut Microbiome Modulation Improves Response to Immune Checkpoint Therapy in Renal Cell Cancer” by Shahla Bari, Duke University
“Ferroptosis Suppressor Protein 1 is a Potent and Targetable Inhibitor of Ferroptosis in Chromophobe Renal Cell” by Samer Salem, Brigham and Women’s Hospital
“Concordance Analysis of Tissue and Circulating Tumor DNA (ctDNA) in Renal Cell Carcinoma (RCC): Insights from a Multimodal Real-World Database” by Chinmay Jani, Sylvester Comprehensive Cancer Center
“Evaluating Intermediate Endpoints for Overall Survival in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors: An IMDC Study” by Renee Maria Saliby, Dana-Farber Cancer Institute
“A Phase 1 Study of Fianlimab (Anti–LAG-3) in Combination with Cemiplimab (Anti–PD-1) in Patients with Advanced ccRCC” by Miso Kim, Seoul National University Hospital
Moderated by Sumanta Pal, City of Hope Comprehensive Cancer Center & Evita Sadimin, City of Hope Comprehensive Cancer Center.
[ad_2]
source
-
-
-
-
